Anemia and iron metabolism in COVID-19 patients (search up to 3 August 2020)
Citation: Taneri P, Gomez-Ochoa S, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. European Journal of Epidemiology 2020;35(8):763-73.
What is this? Iron metabolism and anemia may play an important role in the prognosis of COVID-19 patients.
In this rapid review, the authors searched for observational studies of biomarkers of anemia and iron metabolism in COVID-19 patients. They restricted their searches to articles published in English and did the search up to 3 August 2020. They included 189 studies (57,563 patients), from the Asia Pacific Region (134 studies), Europe (21), the Middle East (14) and the USA (20).
What was found: At the time of this review, the included studies suggested that hemoglobin and ferritin levels in COVID-19 patients vary according to the severity of COVID-19, age, gender and comorbidity.
At the time of this review, the included studies showed that patients with severe COVID-19 had lower red blood cell count and higher red blood cell distribution width than those with moderate COVID-19.
At the time of this review, the meta-analysis showed pathologically high levels of ferritin among COVID-19 patients with significant differences between moderate and severe cases, and between survivors and non-survivors.
At the time of this review, the prognostic capacity of hemoglobin and ferritin was uncertain.
We’ve already reached tens of thousands of people with plain language summaries of systematic reviews. If you’d like to help us to continue our work, please consider a donation.
Donate with PayPal
You can also donate through the Charities Aid Foundation (CAF) here. If you are based in the USA and want to make a tax-deductable donation, please donate to Evidence Aid via the British Schools and Universities Foundation.